Search alternatives:
significantly linear » significant linear (Expand Search), significantly lower (Expand Search), significantly longer (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » greater decrease (Expand Search)
significantly linear » significant linear (Expand Search), significantly lower (Expand Search), significantly longer (Expand Search)
linear decrease » linear increase (Expand Search)
teer decrease » greater decrease (Expand Search)
-
1441
Bending moment in the pressure zone.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1442
Axial forces in the tension zone.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1443
VPF and VIPF.
Published 2025“…Furthermore, parametric studies reveal that the pile base displacement exhibits a non-linear trend of initially decreasing and then increasing with larger inclination angles of the inclined piles. …”
-
1444
-
1445
-
1446
-
1447
-
1448
-
1449
-
1450
-
1451
Baseline characteristics of the study sample<sup>β</sup>μ.
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1452
The flow diagram of the study (CONSORT, 2010).
Published 2024“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
-
1453
-
1454
-
1455
-
1456
-
1457
-
1458
-
1459
-
1460